Tue, 23 Feb 2010 09:51:34 -0500 NUVIS Group http://www.peerviewpress.com Podcast Maker v1.3 - http://www.lemonzdream.com/podcastmaker PeerView Press is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes. Thought leader perspectives on current clinical advances in medicine. PeerView Press is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes. 2010 PeerView Press, 42 Brook Street, Mayfair, London, W1K 5DB webmaster@peerviewpress.com http://media.peerviewpress.com/000136/podcast/nuvis/xml/images/oncology_video_int_144.jpg http://www.peerviewpress.com 144 144 Science & Medicine CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, Oncology no NUVIS Group Moving Ahead in NSCLC With Targeted Therapies Go online to www.peerviewpress.com/h/s186 to view the entire programme with slides. Moving Ahead in NSCLC With Targeted Therapies http://media.peerviewpress.com/000136/podcast/nuvis/m4v/ENUVI06635s186.m4v Tue, 3 May 2011 11:03:54 -0500 Science, Medicine no 00:18:27 lung non-small-cell cancer VEGF EGFR target Avastin bevacizumab guideline maintenance pemetrexed ESMO NUVIS Group Managing Patients With Advanced RCC: Weighing Our Therapeutic Options for Progressive Disease Go online to www.peerviewpress.com/h/p37 to view the entire programme with slides. Managing Patients With Advanced RCC: Weighing Our Therapeutic Options for Progressive Disease http://media.peerviewpress.com/000136/podcast/nuvis/m4v/ANINT07248p37.m4v Wed, 02 Feb 2011 10:20:11 -0500 Science & Medicine no 00:14:35 metastatic renal cell carcinoma, RCC, tyrosine kinase inhibitor, TKIs, mTOR inhibitors, sequential therapy, mRCC, VEGF inhibitors, sunitinib, everolimus, RECORD-1, sorafenib NUVIS Group Journal Club: VEGF Inhibitors for the Treatment of NSCLC Go online to www.peerviewpress.com/h/j8 to view the entire programme with slides. Journal Club: VEGF Inhibitors for the Treatment of NSCLC http://media.peerviewpress.com/000136/podcast/nuvis/m4v/ENUVI07029j8.m4v Wed, 15 Dec 2010 10:20:11 -0500 Science & Medicine no 00:16:33 non-small-cell lung cancer NSCLC VEGF bevacizumab Avastin advanced metastatic targeted safety survival NUVIS Group Targeting the PI3K/Akt/mTOR Signalling Pathway in Breast Cancer: A Pathway With Potential Go online to www.peerviewpress.com/h/r164 to view the entire programme with slides. Targeting the PI3K/Akt/mTOR Signalling Pathway in Breast Cancer: A Pathway With Potential http://media.peerviewpress.com/000136/podcast/nuvis/m4v/ANINT06975r164.m4v Thu, 09 Dec 2010 10:20:11 -0500 Science & Medicine no 00:18:56 PI3K, Akt, mTOR, mammalian target of rapamycin, everolimus, temsirolimus, ridaforolimus, PTEN, BOLERO, signalling, pathway, mutation, HER2 NUVIS Group Focusing on the Factors That Affect Outcomes in Patients With GIST Go online to www.peerviewpress.com/h/s181 to view the entire programme with slides. Focusing on the Factors That Affect Outcomes in Patients With GIST http://media.peerviewpress.com/000136/podcast/nuvis/m4v/ENUVI06464s181.m4v Fri, 26 Nov 2010 10:20:11 -0500 Science & Medicine no 00:16:27 GIST, gastrointestinal stromal tumour, nomogram, Miettinen, AFIP, Fletcher, staging system, risk of recurrence, ACOSOG Z9001, dose escalation, Cmin, plasma trough, gastrectomy, exon 9, exon 11, KIT mutation, metaGIST, survival, TTP, PFS, RFS, ADAGIO, adherence, nonadherence NUVIS Group Journal Club: Discussing the Benefits of Maintenance Therapy in NSCLC Go online to www.peerviewpress.com/h/j9 to view the entire programme with slides. Journal Club: Discussing the Benefits of Maintenance Therapy in NSCLC http://media.peerviewpress.com/000136/podcast/nuvis/m4v/ENUVI06442j9.m4v Fri, 03 Dec 2010 10:20:11 -0500 Science & Medicine no 00:22:56 SATURN, NSCLC, metastatic, advanced lung cancer, maintenance, survival, EGFR, histology, targeted, erlotinib NUVIS Group The Future of Care for Neuroendocrine Tumours: Answering the Call for an Unmet Treatment Need Go online to www.peerviewpress.com/h/r160 to view the entire programme with slides. The Future of Care for Neuroendocrine Tumours: Answering the Call for an Unmet Treatment Need http://media.peerviewpress.com/000136/podcast/nuvis/m4v/NI05777FCr160.m4v Thu, 28 Oct 2010 10:20:11 -0500 Science & Medicine no 00:17:22 pNET, pancreatic neuroendocrine tumour, sunitinib, everolimus, RADIANT-3, TKI, mTOR, tyrosine kinase inhibitor, mammalian target of rapamycin, well-differentiated, moderately differentiated NUVIS Group Journal Club: Targeting Adenocarcinoma in NSCLC With Anti-Angiogenic Therapy Go online to www.peerviewpress.com/h/j6 to view the entire programme with slides. Journal Club: Targeting Adenocarcinoma in NSCLC With Anti-Angiogenic Therapy http://media.peerviewpress.com/000136/podcast/nuvis/m4v/ENUVI06646j6.m4v Mon, 18 Oct 2010 10:20:11 -0500 Science & Medicine no 00:18:38 non-small-cell lung cancer adenocarcinoma survival safety E4599 NSCLC histology nonsquamous bevacizumab targeted NUVIS Group Journal Club: Going on RECORD About a New Treatment Option for Metastatic Renal Cell Carcinoma Go online to www.peerviewpress.com/h/j4 to view the entire programme with slides. Journal Club: Going on RECORD About a New Treatment Option for Metastatic Renal Cell Carcinoma http://media.peerviewpress.com/000136/podcast/nuvis/m4v/NI05776FCj4.m4v Fri, 20 Aug 2010 10:20:11 -0500 Science & Medicine no 00:18:58 renal cell carcinoma, RCC, metastatic, sorafenib, sunitinib, everolimus, mTOR, VEGFR, TKI, tyrosine kinase inhibitor, survival, ranked-preserving structural failure time model, RECORD-1 NUVIS Group EGFR Activating Mutations in NSCLC: A Distinct Type of Cancer Go online to www.peerviewpress.com/h/r147 to view the entire programme with slides. EGFR Activating Mutations in NSCLC: A Distinct Type of Cancer http://media.peerviewpress.com/000136/podcast/nuvis/m4v/ENUVI06443r147.m4v Tue, 03 Aug 2010 10:20:11 -0500 Science & Medicine no 00:24:19 non-small-cell, lung cancer, NSCLC, EGFR positive, TKI, tyrosine kinase, wild-type genetic testing NUVIS Group The Future of Care for Advanced GIST: Using Appropriate Therapies for Optimal Patient Outcomes Go online to www.peerviewpress.com/h/s174 to view the entire programme with slides. The Future of Care for Advanced GIST: Using Appropriate Therapies for Optimal Patient Outcomes http://media.peerviewpress.com/000136/podcast/nuvis/m4v/ANINT06643s174.m4v Fri, 06 Aug 2010 10:20:11 -0500 Science & Medicine no 00:21:47 gastrointestinal stromal tumour, GIST, advanced, imatinib, nilotinib, sunitinib, ENEST g3, BFR14, STOP, continue, mutation, exon, KIT, gastrectomy, third-line NUVIS Group Advances in the Treatment of Breast Cancer: Results From the BIG 1-98 Trial Go online to www.peerviewpress.com/h/j3 to view the entire programme with slides. Advances in the Treatment of Breast Cancer: Results From the BIG 1-98 Trial http://media.peerviewpress.com/000136/podcast/nuvis/m4v/ANINT05996j3.m4v Thu, 29 Apr 2010 10:20:11 -0500 Science & Medicine no 00:19:49 BIG 1-98, letrozole, tamoxifen, sequential, cross-over, censoring, ITT, intention-to-treat, IPCW, inverse proportion censoring weighted, bias, STA, sequential therapy analysis, monotherapy, unblinding, adjuvant, early breast cancer, endocrine responsive NUVIS Group Focusing on the Factors That Affect Outcomes in Patients With GIST Go online to www.peerviewpress.com/h/s168 to view the entire programme with slides. Focusing on the Factors That Affect Outcomes in Patients With GIST http://media.peerviewpress.com/000136/podcast/nuvis/m4v/ANINT06434s168.m4v Fri, 19 Mar 2010 10:20:11 -0500 Science & Medicine no 00:16:43 GIST, gastrointestinal stromal tumour, nomogram, Miettinen, AFIP, Fletcher, staging system, risk of recurrence, ACOSOG Z9001, dose escalation, Cmin, plasma trough, gastrectomy, exon 9, exon 11, KIT mutation, metaGIST, survival, TTP, PFS, RFS, ADAGIO, adherence, nonadherence